Screener
Tandem Diabetes Care TNDM Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by Tandem Diabetes Care in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.
The source filing: Tandem Diabetes Care’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001438133-26-000125
FAQ
- What is Tandem Diabetes Care's accounts receivable?
- Tandem Diabetes Care (TNDM) reported accounts receivable of $162.07M in Q2 2026.
- How has Tandem Diabetes Care's accounts receivable changed year-over-year?
- Tandem Diabetes Care's accounts receivable increased by 26.2% year-over-year, from $128.44M to $162.07M.
- What is the long-term trend for Tandem Diabetes Care's accounts receivable?
- Over 5 years (2020 to 2025), Tandem Diabetes Care's accounts receivable has grown at a 15.0% compound annual growth rate (CAGR), from $82.2M to $165.49M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.
Ask your AI about Tandem Diabetes Care's accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude